FDA clears first automated device to deliver insulin to people with type 2 diabetes

The U.S. Food and Drug Administration on Monday approved the expanded use of an automated insulin pump system to include those with type 2 diabetes. It’s the first such system for use by people with the more prevalent type 2 form of the disease. The FDA first signed off on the system, which automatically adjusts insulin delivery as needed, for type 1 diabetes in 2022. In approving Insulet’s Omnipod 5 insulin delivery system for type 2 diabetes patients, the FDA said the clearance “provides a new option that can automate many of these manual tasks [of tracking and managing blood Read More